CERE Historical PE Ratio image   This CERE PE ratio history page last updated 5/24/2022
CERE Historical PE Ratio Chart
PeriodPriceGAAPAnnualizedPE
Q1 2022
5/10/2022
22.68-0.46-1.84NA
Q4 2021
3/1/2022
28.37-0.40-1.60NA
Q3 2021
11/10/2021
38.67-0.43-1.72NA
Q2 2021
8/11/2021
25.00-0.42-1.68NA
Q1 2021
5/17/2021
13.47-0.40-1.60NA
Q4 2020
3/24/2021
12.50-0.27-1.08NA
Q2 2016
4/14/2016
NA-0.09-0.36NA
Q1 2016
1/14/2016
NA-0.39-1.56NA
Q4 2015
11/23/2015
NA-1.26-5.04NA
Q3 2015
7/10/2015
NA-0.98-3.92NA
Q2 2015
4/9/2015
NA-1.34-5.36NA
Q1 2015
1/13/2015
NA-0.12-0.48NA
Q4 2014
11/20/2014
NA-0.09-0.36NA
Q3 2014
7/10/2014
NA-0.17-0.68NA
Q2 2014
4/10/2014
NA-0.29-1.16NA
Q1 2014
1/9/2014
NA-0.33-1.32NA
Q4 2013
11/21/2013
NA-0.29-1.16NA
Q3 2013
7/11/2013
NA-0.38-1.52NA
Q2 2013
4/11/2013
NA-0.36-1.44NA
Q1 2013
1/10/2013
NA-0.28-1.12NA
Q4 2012
11/20/2012
NA-0.27-1.08NA
CERE PE History Chart
PeriodPriceGAAPTTMPE
Q1 2022
5/10/2022
22.68-0.46-1.29NA
Q4 2021
3/1/2022
28.37-0.40-1.65NA
Q3 2021
11/10/2021
38.67-0.43-1.52NA
Q2 2021
8/11/2021
25.00-0.42-1.18NA
Q1 2021
5/17/2021
13.47-0.40-1.15NA
Q4 2020
3/24/2021
12.50-0.27-2.01NA
Q2 2016
4/14/2016
NA-0.09-2.72NA
Q1 2016
1/14/2016
NA-0.39-3.97NA
Q4 2015
11/23/2015
NA-1.26-3.70NA
Q3 2015
7/10/2015
NA-0.98-2.53NA
Q2 2015
4/9/2015
NA-1.34-1.72NA
Q1 2015
1/13/2015
NA-0.12-0.67NA
Q4 2014
11/20/2014
NA-0.09-0.88NA
Q3 2014
7/10/2014
NA-0.17-1.08NA
Q2 2014
4/10/2014
NA-0.29-1.29NA
Q1 2014
1/9/2014
NA-0.33-1.36NA
Q4 2013
11/21/2013
NA-0.29-1.31NA
Q3 2013
7/11/2013
NA-0.38-1.29NA
Q2 2013
4/11/2013
NA-0.36NANA
Q1 2013
1/10/2013
NA-0.28NANA
Q4 2012
11/20/2012
NA-0.27NANA
Quotes delayed 20 minutes

Email EnvelopeFree CERE Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Cerevel Therapeutics Hldg (CERE) is categorized under the Technology sector; to help you further research PE history across stocks, below are some other companies in the same sector:

CERN PE Ratio History
CERT PE Ratio History
CETX PE Ratio History
CEVA PE Ratio History
CFLT PE Ratio History
CGNX PE Ratio History
CHNG PE Ratio History
CIEN PE Ratio History
CIFR PE Ratio History
CLDR PE Ratio History
How should the CERE historical PE ratio be determined?
Realizing that PE stands for Price to Earnings ratio, we need two values to compute it: stock price and earnings per share. The stock price at any given date is a known historical value, but what about the earnings number to use?

✔️Accepted answer: There are a number of different approaches when it comes to calculating a historical PE ratio for a company like Cerevel Therapeutics Hldg. We like to take our measurements on each of the past quarterly earnings reports. That only leaves the question of whether the earnings number at that quarterly report should be used on an annualized basis, or some other method. We approach this question using three different methods, on this CERE Historical PE Ratio page.

What is the average historical PE for CERE based on annualized quarterly earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use that quarter's earnings result annualized?

✔️Accepted answer: The CERE historical PE ratio using the annualized quarterly earnings method works out to NA.

What is the average historical PE for CERE based on trailing twelve month earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use the trailing twelve months combined earnings result in the calculation?

✔️Accepted answer: The CERE historical PE ratio using the TTM earnings method works out to NA.

On this page we presented the CERE Historical PE Ratio information for Cerevel Therapeutics Hldg' stock. The average CERE historical PE based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is NA. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average CERE historical PE based on this TTM earnings result method is NA. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this CERE historical PE result, against the recent PE: when this page was posted on 5/23/2022, the most recent closing price for CERE had been 25.21, and the most recent quarterly earnings result, annualized, was NA. Meanwhile, the most recent TTM earnings summed to NA.

For self directed investors doing their due diligence on CERE or any other given stock, valuation analysis for CERE can greatly benefit from studying the past earnings and resulting PE calculations. This exercise can help inform an analysis as to whether the past earnings trajectory and current versus historical PE ratios justify the current stock value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Cerevel Therapeutics Hldg PE history or the past PE information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for CERE. Thanks for visiting, and the next time you need to research CERE Historical PE Ratio or the ratio for another stock, we hope you'll think of our site, as your go-to historical PE ratio research resource of choice.

Recommended: ETFs Holding ETH, TOMZ Insider Buying, Funds Holding QCON.

 

CERE Historical PE Ratio | www.HistoricalPERatio.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.